Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Nucleolar Organizer Regions as a Prognostic Indicator for Stage I Non-Small Cell Lung Cancer

Satoshi Kaneko, Teruyoshi Ishida, Kenji Sugio, Hideki Yokoyama and Keizo Sugimachi
Satoshi Kaneko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teruyoshi Ishida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Sugio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Yokoyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keizo Sugimachi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published August 1991
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

When the number of silver-stained nucleolar organizer regions (Ag-NORs) was counted in 274 patients with non-small cell lung cancer, the mean number per nucleus in patients overall was 5.07 ± 1.92 (SD). With the use of the tumor (T)-nodes (N)-metastasis (M) classification, the mean Ag-NOR count for patients with T1 and T2 disease was statistically lower than that for those with T3 and T4 disease (P < 0.01). The mean Ag-NOR counts were lower in patients with N0 disease than in those with N1 and N2 disease (P < 0.01); lower in patients with stage I disease than in those with stage II, IIIA, IIIB, or IV disease (P < 0.01); and lower in patients with adenocarcinoma than in those with squamous cell carcinoma (P < 0.01) or large-cell carcinoma (P < 0.05). In 131 patients with stage I disease, the mean Ag-NOR count was 3.80 ± 1.32, and the 5-year survival rates of patients with Ag-NOR counts of <3.80 and ≥3.80 were 78 and 44%, respectively, including 78% and 25% for adenocarcinoma, respectively (P < 0.01). However, there was no statistically significant difference for those in stage II, IIIA, IIIB, or IV, and in stage I (without an adenocarcinoma). Because patients with stage I non-small cell lung cancer and a high number of Ag-NORs had a poor prognosis, Ag-NORs can serve as a pertinent marker of an early recurrence.

Footnotes

  • ↵1 This work was supported in part by Grant-in-Aid for General Scientific Research 03670659 from the Japanese Ministry of Education, Science, and Culture.

  • ↵2 To whom requests for reprints should be addressed.

  • Received February 28, 1991.
  • Accepted May 23, 1991.
  • ©1991 American Association for Cancer Research.
PreviousNext
Back to top
August 1991
Volume 51, Issue 15
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nucleolar Organizer Regions as a Prognostic Indicator for Stage I Non-Small Cell Lung Cancer
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Nucleolar Organizer Regions as a Prognostic Indicator for Stage I Non-Small Cell Lung Cancer
Satoshi Kaneko, Teruyoshi Ishida, Kenji Sugio, Hideki Yokoyama and Keizo Sugimachi
Cancer Res August 1 1991 (51) (15) 4008-4011;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nucleolar Organizer Regions as a Prognostic Indicator for Stage I Non-Small Cell Lung Cancer
Satoshi Kaneko, Teruyoshi Ishida, Kenji Sugio, Hideki Yokoyama and Keizo Sugimachi
Cancer Res August 1 1991 (51) (15) 4008-4011;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Membership of Awards Assembly
  • Laureates
  • The Role of Chimeric Paired Box Transcription Factors in the Pathogenesis of Pediatric Rhabdomyosarcoma
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement